サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1761149

アフリカの抗がん剤市場規模・予測（2021年～2031年）、地域シェア、動向、成長機会分析レポート：薬剤クラス、適応症、剤形、治療法、セクター、国別

Africa Anticancer Drugs Market Size and Forecast 2021 - 2031, Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Drug Class, Indication, Dosage Form, Therapy, Sector, and Country

出版日
ページ情報
英文 315 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.63円
アフリカの抗がん剤市場規模・予測（2021年～2031年）、地域シェア、動向、成長機会分析レポート：薬剤クラス、適応症、剤形、治療法、セクター、国別
出版日: 2025年06月11日
発行: The Insight Partners
ページ情報: 英文 315 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

アフリカの抗がん剤市場規模は、2024年の18億1,000万米ドルから2031年には32億3,000万米ドルに達すると予測されています。同市場は2025年～2031年にCAGR8.8%で成長すると推定されます。

本レポートで紹介するアフリカの抗がん剤市場予測は、同市場空間の利害関係者が成長戦略を立案する際に役立ちます。がんの罹患率の増加と、がんに対する認識を向上させるためのイニシアチブの急増が、アフリカの抗がん剤市場の成長を促進する主な要因となっています。

がん治療を加速する人工知能

人工知能（AI）は抗がん剤市場において変革の力として台頭しており、遺伝子の多様性、臨床データの不足、個別化治療へのアクセス制限に関連する重大な課題に対処しています。大陸全体でがん患者が大幅に増加する中、AIは創薬を加速させ、治療を最適化し、地域のイノベーションを促進しています。がん検診、診断、治療にAIを実用化することで、がんの早期発見の道が開かれ、患者一人ひとりに合わせた新たな治療計画の開発が加速します。

ケープタウン大学、グラクソ・スミスクライン、ノバルティス、南アフリカ医療研究評議会の協力によるプロジェクト・アフリカGRADIENTは、アフリカの遺伝子プロファイルに合わせた薬剤の調整におけるAIの役割を例証するものです。このイニシアチブは、薬物反応に影響を与える遺伝的変異を考慮することにより、アフリカ人向けにデザインされた治療法の有効性を高めることを目的としています。このアプローチは、治療がより効果的で副作用が少ないことを保証し、患者の転帰を大幅に改善します。さらにAIは、膨大な量の生物学的データを分析して潜在的な薬剤候補を特定することで、創薬プロセスを加速させます。インシリコ・メディシンのような開発企業は、低分子治療法の設計や創薬ターゲットの発見にAI駆動型プラットフォームを採用し、医薬品開発の期間を数年から数ヶ月に短縮しています。このような迅速な開発は、早期発見や治療の選択肢が限られがちなアフリカで、増加するがん負担に対処するために極めて重要です。2023年4月、アストラゼネカ（世界的製薬会社）は、乳がん検出におけるAIの利用を推進するため、南アフリカの医療技術企業MedSol AI Solutionsと手を組みました。両社の協力の中心は、数秒以内に乳がんを特定できる最先端のWi-Fi対応超音波プローブです。同社のMelusi Breast AI迅速検出アプリは、特に恵まれない地域の早期診断を支援するため、地方の診療所に配備されます。専用の紹介システムがこのイニシアチブをバックアップし、陽性結果が出た女性がタイムリーな治療介入を受けられるようにします。このように、アフリカのがん医療にAIが統合されれば、治療成績が向上し、医学研究と開発の自立が促進されます。AIを活用することで、アフリカ諸国は、遺伝的多様性と個別化治療への限られたアクセスがもたらす特有の課題に対処し、より公平なヘルスケアソリューションへの道を開くことができます。したがって、個別化治療を可能にし、医薬品開発を加速し、包括的研究を促進することで、AIはアフリカの抗がん剤市場に新たな動向をもたらしつつあります。

薬剤クラス別では、アフリカの抗がん剤市場は細胞毒性薬、標的薬、ホルモン薬、免疫療法薬、遺伝子治療薬、放射性医薬品、その他に区分されます。細胞毒性薬セグメントは2024年に最大のシェアを占めました。標的薬セグメントは、2025～2031年に最も高いCAGRを記録すると予想されています。

適応症別では、アフリカの抗がん剤市場は肺がん、胃がん、大腸がん、乳がん、前立腺がん、その他に区分されます。肺がんセグメントは2024年に最大の市場シェアを占め、乳がんセグメントは2025～2031年の間に市場で最も高いCAGRを記録すると推定されます。

治療法別では、アフリカの抗がん剤市場は化学療法、標的療法、免疫療法、遺伝子療法、放射性医薬品療法、その他に分類されます。化学療法セグメントは2024年に最大の市場シェアを占め、同セグメントは2025～2031年の間に市場で最も高いCAGRを記録すると推定されます。

剤形別に見ると、アフリカの抗がん剤市場は錠剤・カプセル剤、注射剤、液剤に分類されます。錠剤・カプセル剤は2024年に最大の市場シェアを占め、2025～2031年の市場CAGRは同セグメントが最も高いと推定されます。

セクター別では、市場は公共と民間に二分されます。2024年の市場規模では、公共セグメントが大きなシェアを占めました。2025～2031年のCAGRは、民間セグメントの方が高いと推定されます。

アフリカの抗がん剤市場に関する本レポートの作成にあたり参照した主な一次情報および二次情報は、GLOBOCAN-IARC、WHO Cancer Country Profiles、WHO Global Health Observatory、UN Comtrade Database、IAEA DIRAC、世界銀行、WHO Global Health Expenditure Database、保健省（例：エジプトCAPA、ナイジェリアNHIS）、アフリカ医薬品庁（AMA）、BMI（Fitch）です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • アナリストの市場展望

第3章 調査手法

  • 2次調査
  • 1次調査
    • 仮説の策定
    • マクロ経済要因分析
    • 基礎数値の作成
    • データの三角測量
    • 国レベルのデータ

第4章 アフリカの抗がん剤市場情勢

  • PEST分析
  • がんの有病率：国別
  • がん治療薬価格分析、2024年
  • アフリカにおける輸出入シナリオ
  • エコシステム分析
    • バリューチェーンのベンダー一覧

第5章 アフリカの抗がん剤市場：主要市場力学

  • アフリカの抗がん剤市場：主要市場力学
  • 市場促進要因
    • がん罹患率の上昇
    • がんに対する意識向上への取り組みの増加
  • 市場抑制要因
    • 手頃な価格の抗がん剤が入手できないこと
  • 市場機会
    • 臨床試験数の急増
  • 今後の動向
    • がん治療を加速する人工知能
  • 促進要因と抑制要因の影響

第6章 アフリカの抗がん剤市場：市場分析

  • アフリカの抗がん剤市場の収益、2021年～2031年
  • アフリカの抗がん剤市場の予測分析

第7章 アフリカの抗がん剤市場分析：薬剤クラス別

  • 標的薬
  • ホルモン薬
  • 免疫療法薬
  • 遺伝子治療薬
  • 放射性医薬品
  • その他

第8章 アフリカの抗がん剤市場分析：適応症別

  • 肺がん
  • 胃がん
  • 大腸がん
  • 乳がん
  • 前立腺がん
  • その他

第9章 アフリカの抗がん剤市場分析：剤形別

  • 錠剤・カプセル剤
  • 注射剤
  • 液剤

第10章 アフリカの抗がん剤市場分析：治療法別

  • 化学療法
  • 標的療法
  • 免疫療法
  • 遺伝子療法
  • 放射性医薬品療法
  • その他

第11章 アフリカの抗がん剤市場分析：セクター別

  • 民間
  • 公共

第12章 アフリカの抗がん剤市場：地域別分析

  • アフリカ
    • 南アフリカ
    • エジプト
    • アルジェリア
    • モロッコ
    • チュニジア
    • ナイジェリア
    • ケニア
    • エチオピア
    • ガーナ
    • コートジボワール
    • セネガル
    • リビア
    • その他のアフリカ

第13章 競合情勢

  • ヒートマップ分析：主要企業別
  • 企業のポジショニングと集中度

第14章 業界情勢

  • 市場イニシアティブ
  • パートナーシップと提携
  • その他の開発

第15章 企業プロファイル

  • Amgen Inc
  • Gilead Sciences Inc
  • Novartis AG
  • F. Hoffmann-La Roche Ltd
  • BeiGene Ltd
  • Takeda Pharmaceutical Co Ltd
  • GSK Plc
  • Sanofi SA
  • Cipla Ltd
  • Johnson & Johnson
  • Aspen Holdings
  • Pfizer Inc
  • AstraZeneca Plc
  • Merck & Co Inc
  • Daiichi Sankyo Co Ltd

第16章 付録

図表

List Of Tables

  • Table 1. African Anticancer Drugs Market Segmentation
  • Table 2. Methodology 1 - Africa Market
  • Table 3. Methodology 2 - Africa Market
  • Table 4. Each country's market share is determined using five weighted parameters:
  • Table 5. Market Issues in African Anti-Cancer Drugs Market
  • Table 6. Cancer Prevalence, By Country- 2023
  • Table 7. Cancer Therapeutics, Pricing Analysis (Price (US$/Unit)- 2023
  • Table 8. Import Value and Quantity of Medicinal Products by Key African Countries (2024)
  • Table 9. Export Value and Quantity of Medicinal Products by Key African Countries (2024)
  • Table 10. List of Vendors
  • Table 11. African Anticancer Drugs Market - Revenue, 2021 - 2024 (US$ Million)
  • Table 12. African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million)
  • Table 13. Cytotoxic Drugs: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
  • Table 14. Cytotoxic Drugs: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
  • Table 15. Targeted Drugs: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
  • Table 16. Targeted Drugs: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
  • Table 17. Hormonal Drugs: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
  • Table 18. Hormonal Drugs: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
  • Table 19. African Anticancer Drugs Market - Revenue, 2021 - 2024 (US$ Million) - by Drug Class Type
  • Table 20. African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Drug Class Type
  • Table 21. African Anticancer Drugs Market - Revenue, 2021 - 2024 (US$ Million) - by Cytotoxic Drugs
  • Table 22. African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Cytotoxic Drugs
  • Table 23. African Anticancer Drugs Market - Revenue, 2021 - 2024 (US$ Million) - by Targeted Drugs
  • Table 24. African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Targeted Drugs
  • Table 25. African Anticancer Drugs Market - Revenue, 2021 - 2024 (US$ Million) - by Hormonal Drugs
  • Table 26. African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Hormonal Drugs
  • Table 27. African Anticancer Drugs Market - Revenue, 2021 - 2024 (US$ Million) - by Indication
  • Table 28. African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Indication
  • Table 29. African Anticancer Drugs Market - Revenue, 2021 - 2024 (US$ Million) - by Dosage Form
  • Table 30. African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Dosage Form
  • Table 31. African Anticancer Drugs Market - Revenue, 2021 - 2024 (US$ Million) - by Therapy
  • Table 32. African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Therapy
  • Table 33. African Anticancer Drugs Market - Revenue, 2021 - 2024 (US$ Million) - by Sector
  • Table 34. African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Sector
  • Table 35. South Africa: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Drug Class Type
  • Table 36. South Africa: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Drug Class Type
  • Table 37. South Africa: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Cytotoxic Drugs
  • Table 38. South Africa: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Cytotoxic Drugs
  • Table 39. South Africa: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Targeted Drugs
  • Table 40. South Africa: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Targeted Drugs
  • Table 41. South Africa: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Hormonal Drugs
  • Table 42. South Africa: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Hormonal Drugs
  • Table 43. South Africa: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Indication
  • Table 44. South Africa: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Indication
  • Table 45. South Africa: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Dosage Form
  • Table 46. South Africa: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Dosage Form
  • Table 47. South Africa: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Therapy
  • Table 48. South Africa: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Therapy
  • Table 49. South Africa: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Sector
  • Table 50. South Africa: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Sector
  • Table 51. Egypt: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Drug Class Type
  • Table 52. Egypt: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Drug Class Type
  • Table 53. Egypt: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Cytotoxic Drugs
  • Table 54. Egypt: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Cytotoxic Drugs
  • Table 55. Egypt: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Targeted Drugs
  • Table 56. Egypt: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Targeted Drugs
  • Table 57. Egypt: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Hormonal Drugs
  • Table 58. Egypt: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Hormonal Drugs
  • Table 59. Egypt: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Indication
  • Table 60. Egypt: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Indication
  • Table 61. Egypt: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Dosage Form
  • Table 62. Egypt: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Dosage Form
  • Table 63. Egypt: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Therapy
  • Table 64. Egypt: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Therapy
  • Table 65. Egypt: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Sector
  • Table 66. Egypt: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Sector
  • Table 67. Algeria: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Drug Class Type
  • Table 68. Algeria: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Drug Class Type
  • Table 69. Algeria: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Cytotoxic Drugs
  • Table 70. Algeria: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Cytotoxic Drugs
  • Table 71. Algeria: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Targeted Drugs
  • Table 72. Algeria: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Targeted Drugs
  • Table 73. Algeria: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Hormonal Drugs
  • Table 74. Algeria: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Hormonal Drugs
  • Table 75. Algeria: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Indication
  • Table 76. Algeria: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Indication
  • Table 77. Algeria: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Dosage Form
  • Table 78. Algeria: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Dosage Form
  • Table 79. Algeria: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Therapy
  • Table 80. Algeria: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Therapy
  • Table 81. Algeria: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Sector
  • Table 82. Algeria: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Sector
  • Table 83. Morocco: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Drug Class Type
  • Table 84. Morocco: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Drug Class Type
  • Table 85. Morocco: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Cytotoxic Drugs
  • Table 86. Morocco: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Cytotoxic Drugs
  • Table 87. Morocco: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Targeted Drugs
  • Table 88. Morocco: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Targeted Drugs
  • Table 89. Morocco: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Hormonal Drugs
  • Table 90. Morocco: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Hormonal Drugs
  • Table 91. Morocco: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Indication
  • Table 92. Morocco: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Indication
  • Table 93. Morocco: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Dosage Form
  • Table 94. Morocco: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Dosage Form
  • Table 95. Morocco: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Therapy
  • Table 96. Morocco: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Therapy
  • Table 97. Morocco: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Sector
  • Table 98. Morocco: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Sector
  • Table 99. Tunisia: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Drug Class Type
  • Table 100. Tunisia: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Drug Class Type
  • Table 101. Tunisia: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Cytotoxic Drugs
  • Table 102. Tunisia: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Cytotoxic Drugs
  • Table 103. Tunisia: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Targeted Drugs
  • Table 104. Tunisia: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Targeted Drugs
  • Table 105. Tunisia: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Hormonal Drugs
  • Table 106. Tunisia: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Hormonal Drugs
  • Table 107. Tunisia: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Indication
  • Table 108. Tunisia: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Indication
  • Table 109. Tunisia: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Dosage Form
  • Table 110. Tunisia: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Dosage Form
  • Table 111. Tunisia: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Therapy
  • Table 112. Tunisia: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Therapy
  • Table 113. Tunisia: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Sector
  • Table 114. Tunisia: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Sector
  • Table 115. Nigeria: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Drug Class Type
  • Table 116. Nigeria: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Drug Class Type
  • Table 117. Nigeria: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Cytotoxic Drugs
  • Table 118. Nigeria: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Cytotoxic Drugs
  • Table 119. Nigeria: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Targeted Drugs
  • Table 120. Nigeria: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Targeted Drugs
  • Table 121. Nigeria: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Hormonal Drugs
  • Table 122. Nigeria: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Hormonal Drugs
  • Table 123. Nigeria: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Indication
  • Table 124. Nigeria: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Indication
  • Table 125. Nigeria: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Dosage Form
  • Table 126. Nigeria: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Dosage Form
  • Table 127. Nigeria: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Therapy
  • Table 128. Nigeria: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Therapy
  • Table 129. Nigeria: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Sector
  • Table 130. Nigeria: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Sector
  • Table 131. Kenya: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Drug Class Type
  • Table 132. Kenya: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Drug Class Type
  • Table 133. Kenya: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Cytotoxic Drugs
  • Table 134. Kenya: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Cytotoxic Drugs
  • Table 135. Kenya: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Targeted Drugs
  • Table 136. Kenya: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Targeted Drugs
  • Table 137. Kenya: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Hormonal Drugs
  • Table 138. Kenya: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Hormonal Drugs
  • Table 139. Kenya: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Indication
  • Table 140. Kenya: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Indication
  • Table 141. Kenya: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Dosage Form
  • Table 142. Kenya: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Dosage Form
  • Table 143. Kenya: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Therapy
  • Table 144. Kenya: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Therapy
  • Table 145. Kenya: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Sector
  • Table 146. Kenya: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Sector
  • Table 147. Ethiopia: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Drug Class Type
  • Table 148. Ethiopia: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Drug Class Type
  • Table 149. Ethiopia: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Cytotoxic Drugs
  • Table 150. Ethiopia: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Cytotoxic Drugs
  • Table 151. Ethiopia: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Targeted Drugs
  • Table 152. Ethiopia: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Targeted Drugs
  • Table 153. Ethiopia: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Hormonal Drugs
  • Table 154. Ethiopia: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Hormonal Drugs
  • Table 155. Ethiopia: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Indication
  • Table 156. Ethiopia: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Indication
  • Table 157. Ethiopia: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Dosage Form
  • Table 158. Ethiopia: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Dosage Form
  • Table 159. Ethiopia: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Therapy
  • Table 160. Ethiopia: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Therapy
  • Table 161. Ethiopia: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Sector
  • Table 162. Ethiopia: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Sector
  • Table 163. Ghana: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Drug Class Type
  • Table 164. Ghana: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Drug Class Type
  • Table 165. Ghana: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Cytotoxic Drugs
  • Table 166. Ghana: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Cytotoxic Drugs
  • Table 167. Ghana: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Targeted Drugs
  • Table 168. Ghana: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Targeted Drugs
  • Table 169. Ghana: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Hormonal Drugs
  • Table 170. Ghana: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Hormonal Drugs
  • Table 171. Ghana: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Indication
  • Table 172. Ghana: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Indication
  • Table 173. Ghana: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Dosage Form
  • Table 174. Ghana: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Dosage Form
  • Table 175. Ghana: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Therapy
  • Table 176. Ghana: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Therapy
  • Table 177. Ghana: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Sector
  • Table 178. Ghana: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Sector
  • Table 179. Cote d Ivoire (Ivory Coast): African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Drug Class Type
  • Table 180. Cote d Ivoire (Ivory Coast): African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Drug Class Type
  • Table 181. Cote d Ivoire (Ivory Coast): African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Cytotoxic Drugs
  • Table 182. Cote d Ivoire (Ivory Coast): African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Cytotoxic Drugs
  • Table 183. Cote d Ivoire (Ivory Coast): African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Targeted Drugs
  • Table 184. Cote d Ivoire (Ivory Coast): African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Targeted Drugs
  • Table 185. Cote d Ivoire (Ivory Coast): African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Hormonal Drugs
  • Table 186. Cote d Ivoire (Ivory Coast): African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Hormonal Drugs
  • Table 187. Cote d Ivoire (Ivory Coast): African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Indication
  • Table 188. Cote d Ivoire (Ivory Coast): African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Indication
  • Table 189. Cote d Ivoire (Ivory Coast): African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Dosage Form
  • Table 190. Cote d Ivoire (Ivory Coast): African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Dosage Form
  • Table 191. Cote d Ivoire (Ivory Coast): African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Therapy
  • Table 192. Cote d Ivoire (Ivory Coast): African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Therapy
  • Table 193. Cote d Ivoire (Ivory Coast): African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Sector
  • Table 194. Cote d Ivoire (Ivory Coast): African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Sector
  • Table 195. Senegal: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Drug Class Type
  • Table 196. Senegal: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Drug Class Type
  • Table 197. Senegal: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Cytotoxic Drugs
  • Table 198. Senegal: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Cytotoxic Drugs
  • Table 199. Senegal: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Targeted Drugs
  • Table 200. Senegal: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Targeted Drugs
  • Table 201. Senegal: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Hormonal Drugs
  • Table 202. Senegal: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Hormonal Drugs
  • Table 203. Senegal: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Indication
  • Table 204. Senegal: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Indication
  • Table 205. Senegal: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Dosage Form
  • Table 206. Senegal: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Dosage Form
  • Table 207. Senegal: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Therapy
  • Table 208. Senegal: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Therapy
  • Table 209. Senegal: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Sector
  • Table 210. Senegal: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Sector
  • Table 211. Libya: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Drug Class Type
  • Table 212. Libya: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Drug Class Type
  • Table 213. Libya: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Cytotoxic Drugs
  • Table 214. Libya: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Cytotoxic Drugs
  • Table 215. Libya: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Targeted Drugs
  • Table 216. Libya: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Targeted Drugs
  • Table 217. Libya: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Hormonal Drugs
  • Table 218. Libya: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Hormonal Drugs
  • Table 219. Libya: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Indication
  • Table 220. Libya: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Indication
  • Table 221. Libya: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Dosage Form
  • Table 222. Libya: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Dosage Form
  • Table 223. Libya: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Therapy
  • Table 224. Libya: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Therapy
  • Table 225. Libya: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Sector
  • Table 226. Libya: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Sector
  • Table 227. Rest of Africa: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Drug Class Type
  • Table 228. Rest of Africa: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Drug Class Type
  • Table 229. Rest of Africa: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Cytotoxic Drugs
  • Table 230. Rest of Africa: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Cytotoxic Drugs
  • Table 231. Rest of Africa: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Targeted Drugs
  • Table 232. Rest of Africa: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Targeted Drugs
  • Table 233. Rest of Africa: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Hormonal Drugs
  • Table 234. Rest of Africa: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Hormonal Drugs
  • Table 235. Rest of Africa: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Indication
  • Table 236. Rest of Africa: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Indication
  • Table 237. Rest of Africa: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Dosage Form
  • Table 238. Rest of Africa: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Dosage Form
  • Table 239. Rest of Africa: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Therapy
  • Table 240. Rest of Africa: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Therapy
  • Table 241. Rest of Africa: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Sector
  • Table 242. Rest of Africa: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Sector
  • Table 243. Glossary of Terms, African Anticancer Drugs Market

List Of Figures

  • Figure 1. African Anticancer Drugs Market Segmentation, by Geography
  • Figure 2. PEST Analysis
  • Figure 3. Ecosystem Analysis
  • Figure 4. Impact Analysis of Drivers and Restraints
  • Figure 5. African Anticancer Drugs Market Revenue (US$ Million), 2021-2031
  • Figure 6. African Anticancer Drugs Market Share (%) - by Drug Class Type (2024 and 2031)
  • Figure 7. Cytotoxic Drugs: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 8. Targeted Drugs: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 9. Hormonal Drugs: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 10. Immunotherapy Drugs: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 11. Gene Therapy Drugs: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 12. Radiopharmaceuticals: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 13. Others: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 14. African Anticancer Drugs Market Share (%) - by Indication (2024 and 2031)
  • Figure 15. Lung Cancer: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 16. Stomach Cancer: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 17. Colorectal Cancer: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 18. Breast Cancer: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 19. Prostrate Cancer: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 20. Others: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 21. African Anticancer Drugs Market Share (%) - by Dosage Form (2024 and 2031)
  • Figure 22. Tablet and Capsule: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 23. Injectable: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 24. Liquid: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 25. African Anticancer Drugs Market Share (%) - by Therapy (2024 and 2031)
  • Figure 26. Chemotherapy: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 27. Targeted Therapy: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 28. Immunotherapy: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 29. Gene Therapy: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 30. Radiopharmaceutical Therapy: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 31. Others: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 32. African Anticancer Drugs Market Share (%) - by Sector (2024 and 2031)
  • Figure 33. Private: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 34. Public: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 35. African Anticancer Drugs Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 36. African Anticancer Drugs Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 37. South Africa: African Anticancer Drugs Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 38. Egypt: African Anticancer Drugs Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 39. Algeria: African Anticancer Drugs Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 40. Morocco: African Anticancer Drugs Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 41. Tunisia: African Anticancer Drugs Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 42. Nigeria: African Anticancer Drugs Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 43. Kenya: African Anticancer Drugs Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 44. Ethiopia: African Anticancer Drugs Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 45. Ghana: African Anticancer Drugs Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 46. Cote d Ivoire (Ivory Coast): African Anticancer Drugs Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 47. Senegal: African Anticancer Drugs Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 48. Libya: African Anticancer Drugs Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 49. Rest of Africa: African Anticancer Drugs Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 50. Heat Map Analysis by Key Players
  • Figure 51. Company Positioning and Concentration
目次
Product Code: TIPRE00040929

The Africa anticancer drugs market is expected to reach US$ 3.23 billion by 2031 from US$ 1.81 billion in 2024. The market is estimated to grow with a CAGR of 8.8% from 2025 to 2031.

The Africa anticancer drugs market forecast presented in this report can help stakeholders in this marketplace plan their growth strategies. The increasing incidence of cancer and surging initiatives to improve cancer awareness are the key factors propelling the Africa anticancer drugs market growth.

Artificial Intelligence Accelerating Cancer Care

Artificial Intelligence (AI) is emerging as a transformative force in the anticancer drugs market, addressing critical challenges associated with genetic diversity, scarce clinical data, and limited access to personalized treatments. Amid the vast increase in cancer cases across the continent, AI is accelerating drug discovery, optimizing treatments, and fostering local innovation. The practical application of AI in cancer screening, diagnosis, and care opens the door for early cancer identification and accelerates the development of new treatment plans tailored to each patient.

Project Africa GRADIENT, a collaboration between the University of Cape Town, GlaxoSmithKline, Novartis, and the South African Medical Research Council, exemplifies AI's role in tailoring drugs to African genetic profiles. This initiative aims to enhance the efficacy of treatments designed for African populations by considering genetic variations that influence drug responses. This approach ensures that therapies are more effective and have fewer side effects, significantly improving patient outcomes. Additionally, AI accelerates the drug discovery process by analyzing vast amounts of biological data to identify potential drug candidates. Companies such as Insilico Medicine employ AI-driven platforms to design small-molecule treatments and discover drug targets, reducing drug development timelines from years to months. This rapid development is crucial for addressing the increasing cancer burden in Africa, where early detection and treatment options are often limited. In April 2023, AstraZeneca (a global pharmaceutical company) joined forces with South African health-tech firm MedSol AI Solutions to advance the use of AI in breast cancer detection. Their collaboration centers around a cutting-edge Wi-Fi-enabled ultrasound probe capable of identifying breast cancer within seconds. Their Melusi Breast AI rapid detection app will be deployed in rural clinics to support early diagnosis, particularly in underserved areas. A dedicated referral system backs the initiative to ensure that women with positive results can access timely therapeutic interventions. Thus, AI integration into the cancer care landscape in Africa would enhance treatment outcomes and promote self-reliance in medical research and development. By harnessing AI, African nations can address the unique challenges posed by genetic diversity and limited access to personalized care, paving the way for more equitable healthcare solutions. Hence, by enabling personalized treatments, accelerating drug development, and fostering inclusive research, AI is setting new trends in the Africa anticancer drugs market.

Based on drug class, the Africa anticancer drugs market is segmented into cytotoxic drugs, targeted drugs, hormonal drugs, immunotherapy drugs, gene therapy drugs, radiopharmaceuticals, and others. The cytotoxic drugs segment held the largest share in 2024. The targeted drugs segment is expected to register the highest CAGR during 2025-2031.

Based on indication, the Africa anticancer drugs market is segmented into lung cancer, stomach cancer, colorectal cancer, breast cancer, prostate cancer, and others. The lung cancer segment held the largest market share in 2024, and the breast cancer segment is estimated to register the highest CAGR in the market during 2025-2031.

In terms of therapy type, the Africa anticancer drugs market is categorized into chemotherapy, targeted therapy, immunotherapy, gene therapy, radiopharmaceutical therapy, and others. The chemotherapy segment held the largest market share in 2024, and the same segment is estimated to register the highest CAGR in the market during 2025-2031.

Based on dosage form, the Africa anticancer drugs market is categorized into tablet and capsule, injectable, and liquid. The tablet and capsule segment held the largest market share in 2024, and the same segment is estimated to register the highest CAGR in the market during 2025-2031.

By sector, the market is bifurcated into public and private. The public segment held a larger share of the market in 2024. The private segment is estimated to register a higher CAGR during 2025-2031.

A few of the major primary and secondary sources referred to while preparing the report on the Africa anticancer drugs market are the GLOBOCAN - IARC, WHO Cancer Country Profiles, WHO Global Health Observatory, UN Comtrade Database, IAEA DIRAC, World Bank, WHO Global Health Expenditure Database, Ministries of Health (e.g., Egypt CAPA, Nigeria NHIS), African Medicines Agency (AMA), BMI Fitch).

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Analyst Market Outlook

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country level data:

4. African Anticancer Drugs Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
  • 4.3 Cancer Prevalence, By Country
  • 4.4 Cancer Therapeutics: Pricing Analysis, 2024
  • 4.5 Import-export Scenario in Africa
  • 4.6 Ecosystem Analysis
    • 4.6.1 List of Vendors in the Value Chain

5. African Anticancer Drugs Market - Key Market Dynamics

  • 5.1 African Anticancer Drugs Market - Key Market Dynamics
  • 5.2 Market Drivers
    • 5.2.1 Rising Cancer Incidence
    • 5.2.2 Increasing Initiatives to Improve Cancer Awareness
  • 5.3 Market Restraints
    • 5.3.1 Unaffordability and Limited Availability of Cancer Drugs
  • 5.4 Market Opportunities
    • 5.4.1 Surging Number of Clinical Trials
  • 5.5 Future Trends
    • 5.5.1 Artificial Intelligence Accelerating Cancer Care
  • 5.6 Impact of Drivers and Restraints:

6. African Anticancer Drugs Market - Global Market Analysis

  • 6.1 African Anticancer Drugs Market Revenue (US$ Million), 2021-2031
  • 6.2 African Anticancer Drugs Market Forecast Analysis

7. African Anticancer Drugs Market Analysis - by Drug Class Type

  • 7.1 Cytotoxic Drugs
    • 7.1.1 Overview
    • 7.1.2 Cytotoxic Drugs: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.2 Targeted Drugs
    • 7.2.1 Overview
    • 7.2.2 Targeted Drugs: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.3 Hormonal Drugs
    • 7.3.1 Overview
    • 7.3.2 Hormonal Drugs: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.4 Immunotherapy Drugs
    • 7.4.1 Overview
    • 7.4.2 Immunotherapy Drugs: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.5 Gene Therapy Drugs
    • 7.5.1 Overview
    • 7.5.2 Gene Therapy Drugs: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.6 Radiopharmaceuticals
    • 7.6.1 Overview
    • 7.6.2 Radiopharmaceuticals: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.7 Others
    • 7.7.1 Overview
    • 7.7.2 Others: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)

8. African Anticancer Drugs Market Analysis - by Indication

  • 8.1 Lung Cancer
    • 8.1.1 Overview
    • 8.1.2 Lung Cancer: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.2 Stomach Cancer
    • 8.2.1 Overview
    • 8.2.2 Stomach Cancer: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.3 Colorectal Cancer
    • 8.3.1 Overview
    • 8.3.2 Colorectal Cancer: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.4 Breast Cancer
    • 8.4.1 Overview
    • 8.4.2 Breast Cancer: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.5 Prostrate Cancer
    • 8.5.1 Overview
    • 8.5.2 Prostrate Cancer: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.6 Others
    • 8.6.1 Overview
    • 8.6.2 Others: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)

9. African Anticancer Drugs Market Analysis - by Dosage Form

  • 9.1 Tablet and Capsule
    • 9.1.1 Overview
    • 9.1.2 Tablet and Capsule: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.2 Injectable
    • 9.2.1 Overview
    • 9.2.2 Injectable: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.3 Liquid
    • 9.3.1 Overview
    • 9.3.2 Liquid: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)

10. African Anticancer Drugs Market Analysis - by Therapy

  • 10.1 Chemotherapy
    • 10.1.1 Overview
    • 10.1.2 Chemotherapy: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.2 Targeted Therapy
    • 10.2.1 Overview
    • 10.2.2 Targeted Therapy: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.3 Immunotherapy
    • 10.3.1 Overview
    • 10.3.2 Immunotherapy: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.4 Gene Therapy
    • 10.4.1 Overview
    • 10.4.2 Gene Therapy: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.5 Radiopharmaceutical Therapy
    • 10.5.1 Overview
    • 10.5.2 Radiopharmaceutical Therapy: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.6 Others
    • 10.6.1 Overview
    • 10.6.2 Others: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)

11. African Anticancer Drugs Market Analysis - by Sector

  • 11.1 Private
    • 11.1.1 Overview
    • 11.1.2 Private: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
  • 11.2 Public
    • 11.2.1 Overview
    • 11.2.2 Public: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)

12. African Anticancer Drugs Market - Geographical Analysis

  • 12.1 Africa
    • 12.1.1 African Anticancer Drugs Market Overview
    • 12.1.2 African Anticancer Drugs Market - Revenue, 2021 - 2031 (US$ Million)
      • 12.1.2.1 African Anticancer Drugs Market - Revenue and Forecast Analysis - by Drug Class Type
      • 12.1.2.2 African Anticancer Drugs Market - Revenue and Forecast Analysis - by Cytotoxic Drugs
      • 12.1.2.3 African Anticancer Drugs Market - Revenue and Forecast Analysis - by Targeted Drugs
      • 12.1.2.4 African Anticancer Drugs Market - Revenue and Forecast Analysis - by Hormonal Drugs
      • 12.1.2.5 African Anticancer Drugs Market - Revenue and Forecast Analysis - by Indication
      • 12.1.2.6 African Anticancer Drugs Market - Revenue and Forecast Analysis - by Dosage Form
      • 12.1.2.7 African Anticancer Drugs Market - Revenue and Forecast Analysis - by Therapy
      • 12.1.2.8 African Anticancer Drugs Market - Revenue and Forecast Analysis - by Sector
    • 12.1.3 African Anticancer Drugs Market - Revenue and Forecast Analysis - by Country
      • 12.1.3.1 South Africa: African Anticancer Drugs Market - Revenue, 2021 - 2031 (US$ Million)
        • 12.1.3.1.1 South Africa: African Anticancer Drugs Market Breakdown, by Drug Class Type
        • 12.1.3.1.2 South Africa: African Anticancer Drugs Market Breakdown, by Cytotoxic Drugs
        • 12.1.3.1.3 South Africa: African Anticancer Drugs Market Breakdown, by Targeted Drugs
        • 12.1.3.1.4 South Africa: African Anticancer Drugs Market Breakdown, by Hormonal Drugs
        • 12.1.3.1.5 South Africa: African Anticancer Drugs Market Breakdown, by Indication
        • 12.1.3.1.6 South Africa: African Anticancer Drugs Market Breakdown, by Dosage Form
        • 12.1.3.1.7 South Africa: African Anticancer Drugs Market Breakdown, by Therapy
        • 12.1.3.1.8 South Africa: African Anticancer Drugs Market Breakdown, by Sector
      • 12.1.3.2 Egypt: African Anticancer Drugs Market - Revenue, 2021 - 2031 (US$ Million)
        • 12.1.3.2.1 Egypt: African Anticancer Drugs Market Breakdown, by Drug Class Type
        • 12.1.3.2.2 Egypt: African Anticancer Drugs Market Breakdown, by Cytotoxic Drugs
        • 12.1.3.2.3 Egypt: African Anticancer Drugs Market Breakdown, by Targeted Drugs
        • 12.1.3.2.4 Egypt: African Anticancer Drugs Market Breakdown, by Hormonal Drugs
        • 12.1.3.2.5 Egypt: African Anticancer Drugs Market Breakdown, by Indication
        • 12.1.3.2.6 Egypt: African Anticancer Drugs Market Breakdown, by Dosage Form
        • 12.1.3.2.7 Egypt: African Anticancer Drugs Market Breakdown, by Therapy
        • 12.1.3.2.8 Egypt: African Anticancer Drugs Market Breakdown, by Sector
      • 12.1.3.3 Algeria: African Anticancer Drugs Market - Revenue, 2021 - 2031 (US$ Million)
        • 12.1.3.3.1 Algeria: African Anticancer Drugs Market Breakdown, by Drug Class Type
        • 12.1.3.3.2 Algeria: African Anticancer Drugs Market Breakdown, by Cytotoxic Drugs
        • 12.1.3.3.3 Algeria: African Anticancer Drugs Market Breakdown, by Targeted Drugs
        • 12.1.3.3.4 Algeria: African Anticancer Drugs Market Breakdown, by Hormonal Drugs
        • 12.1.3.3.5 Algeria: African Anticancer Drugs Market Breakdown, by Indication
        • 12.1.3.3.6 Algeria: African Anticancer Drugs Market Breakdown, by Dosage Form
        • 12.1.3.3.7 Algeria: African Anticancer Drugs Market Breakdown, by Therapy
        • 12.1.3.3.8 Algeria: African Anticancer Drugs Market Breakdown, by Sector
      • 12.1.3.4 Morocco: African Anticancer Drugs Market - Revenue, 2021 - 2031 (US$ Million)
        • 12.1.3.4.1 Morocco: African Anticancer Drugs Market Breakdown, by Drug Class Type
        • 12.1.3.4.2 Morocco: African Anticancer Drugs Market Breakdown, by Cytotoxic Drugs
        • 12.1.3.4.3 Morocco: African Anticancer Drugs Market Breakdown, by Targeted Drugs
        • 12.1.3.4.4 Morocco: African Anticancer Drugs Market Breakdown, by Hormonal Drugs
        • 12.1.3.4.5 Morocco: African Anticancer Drugs Market Breakdown, by Indication
        • 12.1.3.4.6 Morocco: African Anticancer Drugs Market Breakdown, by Dosage Form
        • 12.1.3.4.7 Morocco: African Anticancer Drugs Market Breakdown, by Therapy
        • 12.1.3.4.8 Morocco: African Anticancer Drugs Market Breakdown, by Sector
      • 12.1.3.5 Tunisia: African Anticancer Drugs Market - Revenue, 2021 - 2031 (US$ Million)
        • 12.1.3.5.1 Tunisia: African Anticancer Drugs Market Breakdown, by Drug Class Type
        • 12.1.3.5.2 Tunisia: African Anticancer Drugs Market Breakdown, by Cytotoxic Drugs
        • 12.1.3.5.3 Tunisia: African Anticancer Drugs Market Breakdown, by Targeted Drugs
        • 12.1.3.5.4 Tunisia: African Anticancer Drugs Market Breakdown, by Hormonal Drugs
        • 12.1.3.5.5 Tunisia: African Anticancer Drugs Market Breakdown, by Indication
        • 12.1.3.5.6 Tunisia: African Anticancer Drugs Market Breakdown, by Dosage Form
        • 12.1.3.5.7 Tunisia: African Anticancer Drugs Market Breakdown, by Therapy
        • 12.1.3.5.8 Tunisia: African Anticancer Drugs Market Breakdown, by Sector
      • 12.1.3.6 Nigeria: African Anticancer Drugs Market - Revenue, 2021 - 2031 (US$ Million)
        • 12.1.3.6.1 Nigeria: African Anticancer Drugs Market Breakdown, by Drug Class Type
        • 12.1.3.6.2 Nigeria: African Anticancer Drugs Market Breakdown, by Cytotoxic Drugs
        • 12.1.3.6.3 Nigeria: African Anticancer Drugs Market Breakdown, by Targeted Drugs
        • 12.1.3.6.4 Nigeria: African Anticancer Drugs Market Breakdown, by Hormonal Drugs
        • 12.1.3.6.5 Nigeria: African Anticancer Drugs Market Breakdown, by Indication
        • 12.1.3.6.6 Nigeria: African Anticancer Drugs Market Breakdown, by Dosage Form
        • 12.1.3.6.7 Nigeria: African Anticancer Drugs Market Breakdown, by Therapy
        • 12.1.3.6.8 Nigeria: African Anticancer Drugs Market Breakdown, by Sector
      • 12.1.3.7 Kenya: African Anticancer Drugs Market - Revenue, 2021 - 2031 (US$ Million)
        • 12.1.3.7.1 Kenya: African Anticancer Drugs Market Breakdown, by Drug Class Type
        • 12.1.3.7.2 Kenya: African Anticancer Drugs Market Breakdown, by Cytotoxic Drugs
        • 12.1.3.7.3 Kenya: African Anticancer Drugs Market Breakdown, by Targeted Drugs
        • 12.1.3.7.4 Kenya: African Anticancer Drugs Market Breakdown, by Hormonal Drugs
        • 12.1.3.7.5 Kenya: African Anticancer Drugs Market Breakdown, by Indication
        • 12.1.3.7.6 Kenya: African Anticancer Drugs Market Breakdown, by Dosage Form
        • 12.1.3.7.7 Kenya: African Anticancer Drugs Market Breakdown, by Therapy
        • 12.1.3.7.8 Kenya: African Anticancer Drugs Market Breakdown, by Sector
      • 12.1.3.8 Ethiopia: African Anticancer Drugs Market - Revenue, 2021 - 2031 (US$ Million)
        • 12.1.3.8.1 Ethiopia: African Anticancer Drugs Market Breakdown, by Drug Class Type
        • 12.1.3.8.2 Ethiopia: African Anticancer Drugs Market Breakdown, by Cytotoxic Drugs
        • 12.1.3.8.3 Ethiopia: African Anticancer Drugs Market Breakdown, by Targeted Drugs
        • 12.1.3.8.4 Ethiopia: African Anticancer Drugs Market Breakdown, by Hormonal Drugs
        • 12.1.3.8.5 Ethiopia: African Anticancer Drugs Market Breakdown, by Indication
        • 12.1.3.8.6 Ethiopia: African Anticancer Drugs Market Breakdown, by Dosage Form
        • 12.1.3.8.7 Ethiopia: African Anticancer Drugs Market Breakdown, by Therapy
        • 12.1.3.8.8 Ethiopia: African Anticancer Drugs Market Breakdown, by Sector
      • 12.1.3.9 Ghana: African Anticancer Drugs Market - Revenue, 2021 - 2031 (US$ Million)
        • 12.1.3.9.1 Ghana: African Anticancer Drugs Market Breakdown, by Drug Class Type
        • 12.1.3.9.2 Ghana: African Anticancer Drugs Market Breakdown, by Cytotoxic Drugs
        • 12.1.3.9.3 Ghana: African Anticancer Drugs Market Breakdown, by Targeted Drugs
        • 12.1.3.9.4 Ghana: African Anticancer Drugs Market Breakdown, by Hormonal Drugs
        • 12.1.3.9.5 Ghana: African Anticancer Drugs Market Breakdown, by Indication
        • 12.1.3.9.6 Ghana: African Anticancer Drugs Market Breakdown, by Dosage Form
        • 12.1.3.9.7 Ghana: African Anticancer Drugs Market Breakdown, by Therapy
        • 12.1.3.9.8 Ghana: African Anticancer Drugs Market Breakdown, by Sector
      • 12.1.3.10 Cote d Ivoire (Ivory Coast): African Anticancer Drugs Market - Revenue, 2021 - 2031 (US$ Million)
        • 12.1.3.10.1 Cote d Ivoire (Ivory Coast): African Anticancer Drugs Market Breakdown, by Drug Class Type
        • 12.1.3.10.2 Cote d Ivoire (Ivory Coast): African Anticancer Drugs Market Breakdown, by Cytotoxic Drugs
        • 12.1.3.10.3 Cote d Ivoire (Ivory Coast): African Anticancer Drugs Market Breakdown, by Targeted Drugs
        • 12.1.3.10.4 Cote d Ivoire (Ivory Coast): African Anticancer Drugs Market Breakdown, by Hormonal Drugs
        • 12.1.3.10.5 Cote d Ivoire (Ivory Coast): African Anticancer Drugs Market Breakdown, by Indication
        • 12.1.3.10.6 Cote d Ivoire (Ivory Coast): African Anticancer Drugs Market Breakdown, by Dosage Form
        • 12.1.3.10.7 Cote d Ivoire (Ivory Coast): African Anticancer Drugs Market Breakdown, by Therapy
        • 12.1.3.10.8 Cote d Ivoire (Ivory Coast): African Anticancer Drugs Market Breakdown, by Sector
      • 12.1.3.11 Senegal: African Anticancer Drugs Market - Revenue, 2021 - 2031 (US$ Million)
        • 12.1.3.11.1 Senegal: African Anticancer Drugs Market Breakdown, by Drug Class Type
        • 12.1.3.11.2 Senegal: African Anticancer Drugs Market Breakdown, by Cytotoxic Drugs
        • 12.1.3.11.3 Senegal: African Anticancer Drugs Market Breakdown, by Targeted Drugs
        • 12.1.3.11.4 Senegal: African Anticancer Drugs Market Breakdown, by Hormonal Drugs
        • 12.1.3.11.5 Senegal: African Anticancer Drugs Market Breakdown, by Indication
        • 12.1.3.11.6 Senegal: African Anticancer Drugs Market Breakdown, by Dosage Form
        • 12.1.3.11.7 Senegal: African Anticancer Drugs Market Breakdown, by Therapy
        • 12.1.3.11.8 Senegal: African Anticancer Drugs Market Breakdown, by Sector
      • 12.1.3.12 Libya: African Anticancer Drugs Market - Revenue, 2021 - 2031 (US$ Million)
        • 12.1.3.12.1 Libya: African Anticancer Drugs Market Breakdown, by Drug Class Type
        • 12.1.3.12.2 Libya: African Anticancer Drugs Market Breakdown, by Cytotoxic Drugs
        • 12.1.3.12.3 Libya: African Anticancer Drugs Market Breakdown, by Targeted Drugs
        • 12.1.3.12.4 Libya: African Anticancer Drugs Market Breakdown, by Hormonal Drugs
        • 12.1.3.12.5 Libya: African Anticancer Drugs Market Breakdown, by Indication
        • 12.1.3.12.6 Libya: African Anticancer Drugs Market Breakdown, by Dosage Form
        • 12.1.3.12.7 Libya: African Anticancer Drugs Market Breakdown, by Therapy
        • 12.1.3.12.8 Libya: African Anticancer Drugs Market Breakdown, by Sector
      • 12.1.3.13 Rest of Africa: African Anticancer Drugs Market - Revenue, 2021 - 2031 (US$ Million)
        • 12.1.3.13.1 Rest of Africa: African Anticancer Drugs Market Breakdown, by Drug Class Type
        • 12.1.3.13.2 Rest of Africa: African Anticancer Drugs Market Breakdown, by Cytotoxic Drugs
        • 12.1.3.13.3 Rest of Africa: African Anticancer Drugs Market Breakdown, by Targeted Drugs
        • 12.1.3.13.4 Rest of Africa: African Anticancer Drugs Market Breakdown, by Hormonal Drugs
        • 12.1.3.13.5 Rest of Africa: African Anticancer Drugs Market Breakdown, by Indication
        • 12.1.3.13.6 Rest of Africa: African Anticancer Drugs Market Breakdown, by Dosage Form
        • 12.1.3.13.7 Rest of Africa: African Anticancer Drugs Market Breakdown, by Therapy
        • 12.1.3.13.8 Rest of Africa: African Anticancer Drugs Market Breakdown, by Sector

13. Competitive Landscape

  • 13.1 Heat Map Analysis by Key Players
  • 13.2 Company Positioning and Concentration

14. Industry Landscape

  • 14.1 Overview
  • 14.2 Market Initiative
  • 14.3 Partnerships and Collaborations
  • 14.4 Other Developments

15. Company Profiles

  • 15.1 Amgen Inc
    • 15.1.1 Key Facts
    • 15.1.2 Business Description
    • 15.1.3 Products and Services
    • 15.1.4 Financial Overview
    • 15.1.5 SWOT Analysis
    • 15.1.6 Key Developments
  • 15.2 Gilead Sciences Inc
    • 15.2.1 Key Facts
    • 15.2.2 Business Description
    • 15.2.3 Products and Services
    • 15.2.4 Financial Overview
    • 15.2.5 SWOT Analysis
    • 15.2.6 Key Developments
  • 15.3 Novartis AG
    • 15.3.1 Key Facts
    • 15.3.2 Business Description
    • 15.3.3 Products and Services
    • 15.3.4 Financial Overview
    • 15.3.5 SWOT Analysis
    • 15.3.6 Key Developments
  • 15.4 F. Hoffmann-La Roche Ltd
    • 15.4.1 Key Facts
    • 15.4.2 Business Description
    • 15.4.3 Products and Services
    • 15.4.4 Financial Overview
    • 15.4.5 SWOT Analysis
    • 15.4.6 Key Developments
  • 15.5 BeiGene Ltd
    • 15.5.1 Key Facts
    • 15.5.2 Business Description
    • 15.5.3 Products and Services
    • 15.5.4 Financial Overview
    • 15.5.5 SWOT Analysis
    • 15.5.6 Key Developments
  • 15.6 Takeda Pharmaceutical Co Ltd
    • 15.6.1 Key Facts
    • 15.6.2 Business Description
    • 15.6.3 Products and Services
    • 15.6.4 Financial Overview
    • 15.6.5 SWOT Analysis
    • 15.6.6 Key Developments
  • 15.7 GSK Plc
    • 15.7.1 Key Facts
    • 15.7.2 Business Description
    • 15.7.3 Products and Services
    • 15.7.4 Financial Overview
    • 15.7.5 SWOT Analysis
    • 15.7.6 Key Developments
  • 15.8 Sanofi SA
    • 15.8.1 Key Facts
    • 15.8.2 Business Description
    • 15.8.3 Products and Services
    • 15.8.4 Financial Overview
    • 15.8.5 SWOT Analysis
    • 15.8.6 Key Developments
  • 15.9 Cipla Ltd
    • 15.9.1 Key Facts
    • 15.9.2 Business Description
    • 15.9.3 Products and Services
    • 15.9.4 Financial Overview
    • 15.9.5 SWOT Analysis
    • 15.9.6 Key Developments
  • 15.10 Johnson & Johnson
    • 15.10.1 Key Facts
    • 15.10.2 Business Description
    • 15.10.3 Products and Services
    • 15.10.4 Financial Overview
    • 15.10.5 SWOT Analysis
    • 15.10.6 Key Developments
  • 15.11 Aspen Holdings
    • 15.11.1 Key Facts
    • 15.11.2 Business Description
    • 15.11.3 Products and Services
    • 15.11.4 Financial Overview
    • 15.11.5 SWOT Analysis
    • 15.11.6 Key Developments
  • 15.12 Pfizer Inc
    • 15.12.1 Key Facts
    • 15.12.2 Business Description
    • 15.12.3 Products and Services
    • 15.12.4 Financial Overview
    • 15.12.5 SWOT Analysis
    • 15.12.6 Key Developments
  • 15.13 AstraZeneca Plc
    • 15.13.1 Key Facts
    • 15.13.2 Business Description
    • 15.13.3 Products and Services
    • 15.13.4 Financial Overview
    • 15.13.5 SWOT Analysis
    • 15.13.6 Key Developments
  • 15.14 Merck & Co Inc
    • 15.14.1 Key Facts
    • 15.14.2 Business Description
    • 15.14.3 Products and Services
    • 15.14.4 Financial Overview
    • 15.14.5 SWOT Analysis
    • 15.14.6 Key Developments
  • 15.15 Daiichi Sankyo Co Ltd
    • 15.15.1 Key Facts
    • 15.15.2 Business Description
    • 15.15.3 Products and Services
    • 15.15.4 Financial Overview
    • 15.15.5 SWOT Analysis

16. Appendix

  • 16.1 About The Insight Partners
  • 16.2 Glossary of Terms